Data investigation
Is Microdosing Actually Cheaper? We Checked All 556 Sellers
31 sellers publish a microdose tier. The microdose is usually cheaper — but the two prices are quoted on different commitment terms, which is where the comparison breaks.
Microdosing means taking a GLP-1 at less than the approved therapeutic dose — often a quarter to a half of a standard starting dose — usually for appetite control or maintenance rather than to reach a labeled target. It is now sold as its own product tier, and it is almost always advertised as the cheap way in. Whether it is actually cheaper is a harder question than it looks, and not for the reason you would expect.
We checked. Of the 556 sellers in this register, 31 publish a microdose tier with a price. In 26 cases we could compare that tier against the same seller's standard price for the same drug. The microdose was cheaper in 23 of them, at a median of about two-thirds the standard price. That sounds like a clean answer. It is not, and the reason is worth more than the number.
What a microdose actually is
There is no regulatory definition. No microdose regimen appears on an FDA-approved label, no trial has established one, and the doses sold under the name vary widely between sellers. In practice it means a dose below the lowest approved starting dose — below semaglutide's 0.25 mg or tirzepatide's 2.5 mg weekly — and it is a commercial category rather than a clinical one.
Why the price comparison is rigged
Here is what makes the “microdosing is cheaper” comparison unreliable at most sellers: the two prices are usually quoted on different commitment terms. The microdose is shown as a month-to-month rate. The standard dose is shown as an “as low as” figure that requires a six- or twelve-month prepayment. Put side by side on a pricing page they look like two doses. They are two contracts.
Telos Rx is the clearest illustration in our data, and it is not an accusation — every figure below is published on its own site. Its standard compounded tirzepatide is advertised “as low as $139 per month,” which is the twelve-month rate. Its microdosed injection is published as a tier ladder: $279 month-to-month, $234 at three months, $219 at six, $199 at twelve.
| Comparison | Microdose | Standard | Result |
|---|---|---|---|
| Headline against headline | $279 (month-to-month) | $139 (“as low as”) | Microdose looks 2.0× the price |
| Matched at twelve months | $199 | $139 | Microdose is 1.4× the price |
Both rows are true and neither is the comparison a shopper makes on the page. That is the pattern: the term does more work than the dose. We hit the same thing at WeightCare, where a $249 microdose looked more expensive than a $215 standard until you notice the $215 is a six-month plan and the month-to-month standard is $399 — against which the microdose is far cheaper.
How we nearly got this wrong
This is worth showing, because the same traps are sitting on the pricing pages you will read. Our first pass through the register produced a much louder headline — that four sellers charged more for the microdose than the standard dose. Every one of the four was an error in how we asked the question:
- One comparison was against brand Wegovy at $1,695. A compounded microdose is not expensive relative to a brand pen; they are different products.
- One seller matched only because its own record says the microdose tier does not exist. We had matched prose about microdosing rather than a microdose.
- One compared a microdose of tirzepatide against a standard dose of semaglutide. Within tirzepatide, that seller's microdose is cheaper.
- One compared a month-to-month microdose against a six-month standard plan.
Three of the four survived fixing the drug and the form. Two of those three dissolved once the commitment term was matched. A claim that needs four corrections before it holds is a claim we should not make, and the corrections are more useful to you than the claim was.
How to price a microdose properly
- Get both prices on the same term. Ask what the microdose costs month-to-month and what the standard dose costs month-to-month. If the seller only quotes the standard dose as “as low as,” that is a twelve-month number and not the one you will pay in month one.
- Compare the same drug. A microdose of tirzepatide and a standard dose of semaglutide are not alternatives to each other on price.
- Check the billing cadence, not the sentence. One seller in our register advertises a $123 microdose that is actually billed $246 every other month. The monthly figure is honest arithmetic; it is just not a monthly charge.
- Ask what happens when you titrate up. A microdose plan you outgrow is a plan you will be repriced on, and the price you are repriced to is the one that matters.
- Ask what dose, in milligrams. “Microdose” is a marketing word, not a quantity. If nobody will put a number on it, you cannot compare it to anything — and see our units-to-milligrams guide, because a small dose is exactly where the syringe arithmetic gets error-prone.
Common questions
Frequently Asked Questions
Sellers that publish a microdose price
You can see every seller's price rows, including any microdose tier and the term it is quoted on, in the seller reviews. Prices in this register are recorded with the commitment term attached wherever the seller publishes one, precisely because the term is where this comparison goes wrong. Our breakdown of what drives compounded GLP-1 prices covers the rest of the cost structure.
References
- 1.U.S. National Library of Medicine WEGOVY (semaglutide) injection — prescribing information, including approved dosing schedule DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=WEGOVY
- 2.U.S. National Library of Medicine ZEPBOUND (tirzepatide) injection — prescribing information, including approved dosing schedule DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
- 3.U.S. Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products FDA Human Drug Compounding. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
Related research
Is Zepbound a Semaglutide? Brand Names vs Molecules
No — Zepbound is tirzepatide, the same molecule as Mounjaro. Nine brand names cover five molecules, and knowing which is which decides your price and your coverage.
6 min read
The Cheapest Way to Get a GLP-1 Without Insurance
Compounded semaglutide runs $79 to $299 a month across 556 sellers; tirzepatide $99 to $399. The spread is four to one for the same molecule — here is what decides where you land.
8 min read
How to Get a GLP-1 Covered by Insurance
Coverage is decided in three steps, and most people give up at the wrong one. An exclusion and a denial are different things — only one of them is worth appealing.
8 min read
Sermorelin for Weight Loss: Zero Trials, Real History
Approved once as Geref — for growth hormone deficiency in children. Discontinued for commercial reasons, not safety. No published trial has ever tested it for weight loss.
7 min read
Foundayo (Orforglipron): the First GLP-1 Pill for Weight
Approved 1 April 2026 as the first GLP-1 tablet for weight management — taken with or without food, no injection. It produced 11.1% weight loss at 72 weeks, below both injectable rivals. The label, the trials and the interactions.
9 min read
GLP-1 Prior Authorization: the Criteria, the Clock, the Appeal
You have 180 days to appeal a denied GLP-1 prescription and your insurer has 30 to answer. If they refuse again an independent reviewer decides — and the insurer is bound by it. The federal deadlines, verified.
7 min read
Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Gala
Moving between compounded and brand without changing seller
From $149/mo
Get started →Synergy Rx
Knowing which pharmacy fills the vial — it names Belmar Pharmacy
From $349/mo
Get started →Strut Health
Semaglutide at $99/month, 48% under the register median
From $199/mo
Get started →